GXO Logistics (GXO) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 revenue reached a record $2.85 billion, up 19% year-over-year, with 2% organic growth, driven by the Wincanton and PFS acquisitions and organic expansion in the UK and Ireland.
Net income was $39 million, down 41% year-over-year, impacted by higher transaction, integration, and litigation costs.
Completed the $958 million Wincanton acquisition, expanding presence in the UK, Ireland, and Europe, and targeting $55 million in synergies.
Signed $270 million in new business in Q2; sales pipeline at a 12-month high of $2.3 billion.
Reaffirmed full-year 2024 guidance and remain confident in 2027 targets.
Financial highlights
Adjusted EBITDA for Q2 was $187 million; free cash flow reached $31 million, and operating cash flow was $115 million.
Diluted EPS was $0.32; adjusted diluted EPS was $0.55.
Net leverage at 3.1x, with net debt at $2.3 billion and expectations to reduce to 2.5x by year-end and below 2x by end of 2025.
No debt maturities in 2024; $1.4 billion liquidity available at end Q2.
Operating return on invested capital was 32% in Q2 2024.
Outlook and guidance
Full-year 2024 guidance: organic revenue growth of 2%–5%, adjusted EBITDA of $805M–$835M, and adjusted EPS of $2.73–$2.93.
Expect EBITDA to free cash flow conversion of 30%–40%.
2027 targets: $15.5B–$16B revenue and $1.25B–$1.3B adjusted EBITDA.
Anticipate stronger Q4 due to easier comps and higher new business contributions.
Sufficient liquidity and cash flow expected to fund operations and obligations for at least the next 12 months.
Latest events from GXO Logistics
- Record revenue and new business wins drive strong 2026 outlook and margin expansion.GXO
Q4 202511 Feb 2026 - Q3 revenue up 28% to $3.2B, strong pipeline, but net income down on higher costs.GXO
Q3 202416 Jan 2026 - Record 2024 results and strong 2025 outlook with margin expansion and robust pipeline.GXO
Q4 202415 Dec 2025 - 2024 saw record results, board refreshment, and a focus on ESG and pay-for-performance.GXO
Proxy Filing1 Dec 2025 - Q2 2025 revenue up 16%, guidance raised, Wincanton deal approved, CEO transition underway.GXO
Q2 202523 Nov 2025 - Q1 revenue up 21% to $3B, net loss $95M, guidance reaffirmed, and NHS contract boosts outlook.GXO
Q1 202519 Nov 2025 - Record Q3 revenue, 71% net income growth, and robust pipeline drive strong outlook.GXO
Q3 202513 Nov 2025